IMPLEMENTATION BRIEF
Access considerations for innovative treatments
This brief offers a checklist of key steps that different stakeholders should consider to ensure patients have access to innovative treatments. These therapies present unique challenges for different stakeholders and require collaboration between these parties to ensure that patients receive the best treatment for their condition.
Get the implementation brief
Recent news
Mara Palm joins NEWDIGS
Jul 18, 2024NEWDIGS leaders named to Illinois SCD Advisory Council
Jul 02, 2024ISPOR 2024 panel recap: Will the Pediatric Rare Disease Pipeline Create a Financial Tsunami? Implications of a Monte Carlo Projection
May 21, 2024BioCentury OpEd: Biomedical Innovation Requires Health System Innovation
May 14, 2024Managing the Challenges of Paying for Gene Therapy: New ICER / NEWDIGS whitepaper
Apr 23, 2024Our mission is to improve health outcomes by accelerating appropriate, timely, and equitable patient access to biomedical products in ways that work for all stakeholders.
We design and catalyze solutions with an integrated systems view through complementary approaches of public-private partnerships (our consortium), sponsored research, custom education, and experiential action learning.